GMT Capital’s Aceragen Inc ACGN Stock Holding History

GMT Capital’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-15,749	Closed	-$3.94M	–	117
2018 Q1	$3.94M	Buy	15,749 +1,486	+10%	+$408K	0.09%	82
2017 Q4	$4.09M	Buy	+14,263	New	+$4.07M	0.08%	92

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GMT Capital's ACGN Position: Q2 2018 in Review

GMT Capital sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 15,749 shares — an estimated $3.94M sold.

GMT Capital first reported a position in ACGN in Q4 2017 and held it in 2 quarters. The position peaked at $4.09M in Q4 2017. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

GMT Capital reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
GMT Capital sold 15,749 Aceragen Inc shares in Q2 2018, an estimated $3.94M.
GMT Capital first reported a position in Aceragen Inc in Q4 2017 and held it in 2 quarters.
GMT Capital's Aceragen Inc position peaked at $4.09M in Q4 2017.
93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on GMT Capital's 13F filing for Q2 2018, filed 14 Aug 2018.